首页> 外文期刊>Drug delivery and translational research >Reliability and accuracy of intradermal injection by Mantoux technique, hypodermic needle adapter, and hollow microneedle in pigs
【24h】

Reliability and accuracy of intradermal injection by Mantoux technique, hypodermic needle adapter, and hollow microneedle in pigs

机译:Mantoux技术,皮下注射针头适配器和空心微针在猪中进行皮内注射的可靠性和准确性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We compared the ability of three intradermal delivery devices to administer an intended dose to pig skin in vivo and target that dose to the dermal rather than subcutaneous layers. The three devices were a standard hypodermic needle and syringe for the Mantoux technique, an adapter designed to facilitate proper hypodermic needle and syringe use, and a hollow microneedle. Reliability was determined as the percentage of the administered dose that entered the skin, as opposed to remaining in the device or on the skin surface. The intradermal adapter (97.6 ± 1.5 % delivered, mean ± standard deviation), Mantoux technique (95.4 ± 4.9 %), and hollow microneedle (94.9 ± 0.3 %) exhibited similar reliability. Accuracy was determined as the percentage of the dose that entered the skin that localized in the dermis. All three devices achieved similar accuracy: hollow microneedle (99 ± 12 % delivered to the dermis, median ± standard deviation), Mantoux technique (97 ± 16 %), and intradermal adapter (92 ± 21 %). We conclude that intradermal injection by all three methods studied provided reliable delivery to the skin and provided accurate localization of delivery within the dermis. Next-generation designs of these devices have now received clearance from the FDA and are used as medical products and/or in clinical trials.
机译:我们比较了三种皮内递送装置在体内对猪皮施用预期剂量并将该剂量靶向真皮而不是皮下层的能力。这三种设备是用于Mantoux技术的标准皮下注射针头和注射器,设计用于促进正确使用皮下注射针头和注射器的适配器以及空心微针。可靠性确定为进入皮肤的给药剂量的百分比,而不是残留在设备中或皮肤表面上。皮内适配器(97.6±1.5%,平均±标准偏差),Mantoux技术(95.4±4.9%)和空心微针(94.9±0.3%)表现出相似的可靠性。准确度确定为进入真皮中真皮的进入皮肤的剂量百分比。所有这三种设备均达到了相似的精度:空心微针(输送至真皮的99±12%,中位数±标准偏差),Mantoux技术(97±16%)和皮内适配器(92±21%)。我们得出的结论是,通过所研究的所有三种方法进行的皮内注射可向皮肤提供可靠的递送,并提供真皮内递送的精确定位。这些设备的下一代设计现已获得FDA的批准,可用于医疗产品和/或用于临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号